Journal of Diabetes and Its Complications
Volume 24, Issue 5 , Pages 345-353 , September 2010

Substantially increased risk of cancer in patients with diabetes mellitus: A systematic review and meta-analysis of epidemiologic evidence in Japan

  • Hiroshi Noto

      Affiliations

    • Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
    • ,
  • Keiichiro Osame

      Affiliations

    • Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
    • ,
  • Takehiko Sasazuki

      Affiliations

    • National Center for Global Health and Medicine, Tokyo 162-8655, Japan
    • ,
  • Mitsuhiko Noda

      Affiliations

    • Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
    • Corresponding Author InformationCorresponding author. Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan. Tel.: +81 3 3202 7181; fax: +81 3 3207 1038.

Received 31 March 2010 ,Revised 14 June 2010 ,Accepted 23 June 2010.

References 

  1. Barclay AW, Petocz P, McMillan-Price J, et al. Glycemic index, glycemic load, and chronic disease risk–a meta-analysis of observational studies. American Journal of Clinical Nutrition. 2008;87:627–637
  2. Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. Journal of the American Medical Association. 2008;300:2754–2764
  3. Bell RH, McCullough PJ, Pour PM. Influence of diabetes on susceptibility to experimental pancreatic cancer. American Journal of Surgery. 1988;155:159–164
  4. Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia. 2004;47:1071–1078
  5. Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000;23:465–471
  6. Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. American Journal of Obstetrics and Gynecology. 1992;167:1317–1325
  7. Bruning PF, Bonfrer JM, van Noord PA, et al. Insulin resistance and breast-cancer risk. International Journal of Cancer. 1992;52:511–516
  8. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. Journal of the American Medical Association. 2009;301:2129–2140
  9. Chan WB, Tong PC, Chow CC, et al. The associations of body mass index, C-peptide and metabolic status in Chinese type 2 diabetic patients. Diabetic Medicine. 2004;21:349–353
  10. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52:1766–1777
  11. Dhindsa S, Prabhakar S, Sethi M, et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism. 2004;89:5462–5468
  12. Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. Journal of the American Medical Association. 2006;295:1288–1299
  13. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clinical Gastroenterology and Hepatology. 2006;4:369–380
  14. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. Journal of the American Medical Association. 1995;273:1605–1609
  15. Fisher WE, Boros LG, O'Dorisio TM, et al. GI hormonal changes in diabetes influence pancreatic cancer growth. Journal of Surgical Research. 1995;58:754–758
  16. Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: A meta-analysis. Diabetologia. 2007;50:1365–1374
  17. Fujino Y, Mizoue T, Tokui N, et al. Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes/Metabolism Research and Reviews. 2001;17:374–379
  18. Fukushima M, Usami M, Ikeda M, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: A cross-sectional study of Japanese type 2 diabetes. Metabolism. 2004;53:831–835
  19. Gapstur SM, Gann PH, Lowe W, et al. Abnormal glucose metabolism and pancreatic cancer mortality. Journal of the American Medical Association. 2000;283:2552–2558
  20. Giovannucci E. Insulin and colon cancer. Cancer Causes & Control. 1995;6:164–179
  21. Goodman MT, Cologne JB, Moriwaki H, et al. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Preventive Medicine. 1997;26:144–153
  22. Grossmann M, Thomas MC, Panagiotopoulos S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. Journal of Clinical Endocrinology and Metabolism. 2008;93:1834–1840
  23. Hotta N, Nakamura J, Iwamoto Y, et al. Causes of death in Japanese diabetics based on the results of a survey of 18,385 diabetics during 1991–2000―Report of Committee on Cause of Death in Diabetes Mellitus. Journal of Japan Diabetes Society. 2007;50:47–61
  24. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. Journal of the National Cancer Institute. 1999;91:542–547
  25. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. British Journal of Cancer. 2005;92:2076–2083
  26. Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in Japan. Archives of Internal Medicine. 2006;166:1871–1877
  27. Inoue M, Okayama A, Fujita M, et al. A case-control study on risk factors for uterine endometrial cancer in Japan. Japanese Journal of Cancer Research. 1994;85:346–350
  28. Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women. Journal of the American Medical Association. 2005;293:194–202
  29. Kaaks R. Nutrition, hormones, and breast cancer: Is insulin the missing link?. Cancer Causes & Control. 1996;7:605–625
  30. Kadowaki T, Miyake Y, Hagura R, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 1984;26:44–49
  31. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124:823–835
  32. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention. 2006;15:2056–2062
  33. Khan M, Mori M, Fujino Y, et al. Site-specific cancer risk due to diabetes mellitus history: Evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pacific Journal of Cancer Prevention. 2006;7:253–259
  34. Kim YI. Diet, lifestyle, and colorectal cancer: Is hyperinsulinemia the missing link?. Nutrition Reviews. 1998;56:275–279
  35. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. European Journal of Cancer Prevention. 2007;16:83–89
  36. Kuroe A, Fukushima M, Usami M, et al. Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Research and Clinical Practice. 2003;59:71–77
  37. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: A meta-analysis. International Journal of Cancer. 2007;121:856–862
  38. Larsson SC, Orsini N, Brismar K, et al. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49:2819–2823
  39. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: A meta-analysis. Journal of the National Cancer Institute. 2005;97:1679–1687
  40. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. New England Journal of Medicine. 1997;336:633–640
  41. Li D, Yeung SC, Hassan MM, et al. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009;137:482–488
  42. Libby G, Donnelly LA, Donnan PT, et al. New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes. Diabetes Care. 2009;32:1620–1625
  43. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Annals of Internal Medicine. 2009;151:W65–W94
  44. Lin Y, Tamakoshi A, Kawamura T, et al. Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. International Journal of Cancer. 2002;99:742–746
  45. Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia. 1999;42:107–112
  46. Luo J, Iwasaki M, Inoue M, et al. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: A large-scale population-based cohort study in Japan—the JPHC study. Cancer Causes & Control. 2007;18:603–612
  47. Matsuo M. Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case-control study. Kurume Medical Journal. 2003;50:91–98
  48. McCall JL, Tuckey JA, Parry BR. Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer. British Journal of Surgery. 1992;79:1361–1363
  49. Ministry of Health, Labour and Welfare of Japan . Patient Survey. 2005;
  50. Ministry of Health, Labour and Welfare of Japan . National Health and Nutrition Survey. 2007;
  51. Mizuno S, Watanabe S, Nakamura K, et al. A multi-institute case-control study on the risk factors of developing pancreatic cancer. Japanese Journal of Clinical Oncology. 1992;22:286–291
  52. Morss AS, Edelman ER. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. Journal of Biological Chemistry. 2007;282:14635–14644
  53. Noguchi Y, Yoshikawa T, Marat D, et al. Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle. Biochemical and Biophysical Research Communications. 1998;253:887–892
  54. Oba S, Nagata C, Nakamura K, et al. Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: A population-based prospective cohort study in Japan. Journal of Epidemiology. 2008;18:197–203
  55. Richardson LC, Pollack LA. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nature Clinical Practice Oncology. 2005;2:48–53
  56. Seow A, Yuan JM, Koh WP, et al. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. Journal of the National Cancer Institute. 2006;98:135–138
  57. Shibata A, Ogimoto I, Kurozawa Y, et al. Past medical history and risk of death due to hepatocellular carcinoma, univariate analysis of JACC study data. Kurume Medical Journal. 2003;50:109–119
  58. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. British Journal of Cancer. 1999;80:1830–1837
  59. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Journal of the American Medical Association. 2000;283:2008–2012
  60. Tazawa J, Maeda M, Nakagawa M, et al. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Digestive Diseases and Sciences. 2002;47:710–715
  61. Torisu Y, Ikeda K, Kobayashi M, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Hepatology Research. 2007;37:517–523
  62. Uetake S, Yamauchi M, Itoh S, et al. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcoholism, Clinical and Experimental Research. 2003;27:47S–51S
  63. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Journal of Clinical Epidemiology. 2008;61:344–349
  64. Waki K, Noda M, Sasaki S, et al. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: A population-based prospective study in the JPHC study cohort. Diabetic Medicine. 2005;22:323–331
  65. Washio M, Mori M, Khan M, et al. Diabetes mellitus and kidney cancer risk: The results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). International Journal of Urology. 2007;14:393–397
  66. White MF. The insulin signalling system and the IRS proteins. Diabetologia. 1997;40(Suppl. 2):S2–S17
  67. Wolf I, Sadetzki S, Catane R, et al. Diabetes mellitus and breast cancer. Lancet Oncology. 2005;6:103–111
  68. Yamazawa K, Matsui H, Seki K, et al. A case-control study of endometrial cancer after antipsychotics exposure in premenopausal women. Oncology. 2003;64:116–123
  69. Yu H, Berkel H. Insulin-like growth factors and cancer. Journal of the Louisiana State Medical Society. 1999;151:218–223
  70. Zhang W, Thornton WH, MacDonald RS. Insulin-like growth factor-I and II receptor expression in rat colon mucosa are affected by dietary lipid intake. Journal of Nutrition. 1998;128:158–165

☆ This study was supported by a Health Sciences Research Grant (Research on Diabetes H20-002; Comprehensive Research on Diabetes/Cardiovascular and Life-Style Related Diseases H22-019) from the Ministry of Health, Labour and Welfare of Japan.

☆☆ Conflict of interest: None.

PII: S1056-8727(10)00069-3

doi: 10.1016/j.jdiacomp.2010.06.004

Journal of Diabetes and Its Complications
Volume 24, Issue 5 , Pages 345-353 , September 2010

Article Tools

* Image Usage & Resolution